HOME JOURNALS CONTACT

Asian Journal of Clinical Nutrition

Year: 2017 | Volume: 9 | Issue: 3 | Page No.: 124-130
DOI: 10.3923/ajcn.2017.124.130
Body Mass Index, Nutrient Intakes and Serum Anti-oxidant Status of Elderly Men with and Without Benign Prostatic Hyperplasia in Ibadan, Nigeria
Fadupin Grace, Sosanya Mercy and Atinmo Tola

Abstract: Background and Objective: Worldwide, approximately 30 million men have symptoms related to benign prostatic hyperplasia (BPH). There is a high prevalence of the disease, therefore, the associated costs of medical care are also high. Little is documented on the nutritional status of men with BPH in sub-Saharan Africa. This study therefore aimed to determine the body mass index (BMI), nutrient intakes and serum antioxidant status of male adults with and without BPH (benign prostatic hyperplasia) in Ibadan. Materials and Methods: This case-controlled, analytical study recruited 28 male adults with BPH from the Urology Section of the Surgical Out-patients Department, University College Hospital, Ibadan and the controls were 17 male adults without BPH, age-matched, living in the same city. BMI was computed and mean daily nutrient intakes were assessed using repeated 24 h dietary recalls and analyzed using the software "Total Diet Assessment". Beta-carotene, retinol and lycopene levels in the serum of the respondents were also determined using high performance liquid chromatography. Statistical analysis was done using SPSS. Results: There were no significant differences in the BMI, carbohydrate, fat, protein, energy, iron, sodium and zinc intakes between both groups (p>0.05). However, potassium intakes (807.3±352.2 mg vs 567.2 ±278.2 mg) and calcium intakes (188.3±163.6 mg vs 103.8±62.3 mg) of the BPH and controls differed significantly (p = 0.021 and 0.048, respectively). Lycopene (2443.1±265.4 μg) and beta-carotene (8.6±0.3 mg) intakes of the BPH were significantly lower than those of the controls (3862.3±316.2 μg and 10.1±8.3 mg) respectively, p<0.05. The mean serum lycopene, beta-carotene and retinol (24.2±10.2, 47.7±28.8 and 356.9±150.7 ng mL–1) of the BPH were significantly lower than the values 70.8±49.8, 57.6±47.7 and 395.4±275.6 ng mL–1 of the controls respectively (p<0.05). A significant inverse correlation was observed between serum lycopene and BPH (r = -0.552, p = 0.000). Conclusion: Elderly men had low nutrient intakes and the mean calcium and potassium intakes of men with BPH were significantly higher than that of men without BPH, while the mean lycopene and beta-carotene intakes of men without BPH were significantly higher than those with BPH. Furthermore, the serum antioxidant status of men with BPH was significantly lower than that of men without BPH.

Fulltext PDF Fulltext HTML

How to cite this article
Fadupin Grace, Sosanya Mercy and Atinmo Tola, 2017. Body Mass Index, Nutrient Intakes and Serum Anti-oxidant Status of Elderly Men with and Without Benign Prostatic Hyperplasia in Ibadan, Nigeria. Asian Journal of Clinical Nutrition, 9: 124-130.

Keywords: male adults, body mass index, serum antioxidants, Nutrient intakes and benign prostatic hyperplasia

INTRODUCTION

Benign prostatic hyperplasia (BPH) is a common disease of elderly men and a risk factor for developing prostate cancer later in life1. Worldwide, approximately 30 million men have symptoms related to benign prostatic hyperplasia2. Little is documented on the prevalence of BPH in Sub-Saharan Africa3. In Nigeria however, the prevalence of BPH has been shown to be as high as 25-35%4. There is a high prevalence of the disease, therefore the associated costs of medical care are also high (approximately 4 billion dollars/year in the United States)5.

Data from epidemiologic studies provide evidence of a possible significant relationship between dietary habits and the incidence of prostate disorders, with dietary factors including different issues such as the total caloric intake, macronutrients (carbohydrates, proteins and fat) and micronutrients (vitamins and minerals)6.

According to Ejike and Ezeanyika3 the eating of processed foods and a sedentary lifestyle apparently are status symbols among the middle and upper classes in Sub-Saharan Africa, resulting in a surge in the disease burden of Sub-Saharan Africa. Clinically apparent BPH represents a considerable health problem for elderly men due to the negative effects it has on quality of life7. Wang et al.8 have indicated an association between body mass index and increased risk of BPH. Benign prostatic hyperplasia may also be caused or exacerbated by chronic inflammation and subsequent oxidative damage9 and thus dietary factors such as n-3 fatty acids, polyunsaturated fats and antioxidants may also affect risk.

Antioxidant nutrients that might influence cell growth and differentiation may beneficially influence disorders underlying BPH10. Retinol and its natural metabolites and synthetic derivatives play important roles in regulating cell proliferation, differentiation, cell arrest at G1 phase and embryonic development11. A re-analysis of physician's health study data provides insight which lends support to the idea that beta-carotene may be protective against prostate enlargement at the doses available from dietary intake12.

The abundance of lycopene in prostatic tissue is indirectly implicated in the chemoprevention of pathologies likely to affect the prostate gland in the ageing male, such as slowing the progression of BPH13. The common pathologic hyper-proliferation of prostate cells in adult men developing BPH may be positively affected by lycopene14. Schwarz et al.15 also observed that there was no progression of BPH in patients supplemented with lycopene as compared with a placebo group. The novel finding that lycopene reduces local androgen signaling in the prostate also suggests efficacy in prevention of benign prostate hyperplasia.

In Nigeria, there is a dearth of information on the nutrient and antioxidant intakes of male adults, since they do not represent a vulnerable segment of the population. Furthermore, there is sparse documentation of the relationship between nutritional status and BPH. This study therefore aimed at determining the nutritional status (body mass index, nutrient intakes and serum levels of antioxidants) of male adults with and without BPH and exploring the relationship between their nutritional status and BPH.

MATERIALS AND METHODS

This case-control study of males with and without BPH was carried out in accordance with the ethical standards of the University of Ibadan/University College Hospital Ibadan Ethical Review Committee. Twenty-eight subjects (cases) were randomly selected from the Urology Division of the Outpatient Department of Surgery of the University College Hospital, Ibadan, Oyo state, Nigeria. Criteria for inclusion were histologically confirmed, symptomatic (BPH), high serum PSA or high Prostate Symptom Scores16, age above 40 years, absence of acute illness and informed consent of willingness to participate in the study. The presence of chronic diseases of the liver and kidneys, histologically confirmed malignancies and inflammatory diseases of the urogenital tract were the exclusion criteria. The controls were seventeen17 men age-matched and living in the same city, with low serum PSA and who did not report any of the symptoms of prostate enlargement (the controls have been described previously18, as this study was part of a comprehensive study).

A semi-structured questionnaire was used to collect socio-demographic data (Table 1). Their weights and heights were measured and body mass index (BMI) was computed from their weight and height measurements (Fig. 1). Researchers assessed and analyzed the respondents’ daily nutrient intakes using repeated 24 h dietary recalls and an adapted version of the food database ‘total diet assessment 3.0".

Serum lycopene, beta-carotene and retinol of the respondents were extracted from a single 5 mL blood sample drawn from each subject by venipuncture by a phlebotomist using a method similar to that described by Tzeng et al.17 and determined using high performance liquid chromatography (a C18 column, a Rheodyne model 7161 injector, an Agilent model 1100 pump, an Agilent model 1100 UV-VIS detector (wavelength of 272 nm), a binary solvent system of HPLC-grade methanol/deionised water (95:5, v/v), flow rate of 1 mL min‾1) (Detailed procedures have been described elsewhere)18.

Fig. 1:Body mass index of the respondents

Table 1:Socio-economic characteristics of the respondents
No significant differences (p>0.05) were observed in the mean ages of the BPH and the control (59.5±12.5 years versus 63.8±8.7 years). Other socio-demographic characteristics such as income, occupation and educational status also did not differ significantly between the groups (p>0.05), BPH = Benign prostatic hyperplasia, SD = Standard deviation

Statistical analysis: The data were analyzed by computing frequencies, percentages, means and standard deviations of the various variables. Chi-square tests were done to ascertain if there were any significant differences in the socio-demographic characteristics of the respondents. Student’s t-test was used to test for differences in mean BMI, nutrient intakes and serum antioxidant levels. The mean nutrient intakes were also compared with the daily required intake (DRI) for men19,20. Spearman’s rank correlation was used to assess the relationship between their serum and dietary antioxidant status and BPH. All analysis were done at the 0.05 level of significance using Statistical Package for the Social Sciences (SPSS) software (version 16.0 for Windows; SPSS Inc., Chicago, IL).

RESULTS

The body mass index of the respondents did not differ significantly between the BPH and controls (t = 0.742, p = 0.462).

The mean daily nutrient intakes of the respondents is shown in Table 2. The mean carbohydrate, energy, protein, fat, magnesium and zinc intakes of the respondents were not significantly different (p>0.05). However the mean calcium and potassium intakes of the BPH group were significantly higher than those of the controls (p = 0.048 and 0.021, respectively). Conversely, the mean lycopene and beta-carotene intakes (3862.2±316.4 μg and 10.1±8.3 mg) of the controls were significantly higher than that of the BPH group (2443.1±265.4 μg and 8.6±5.3 mg) (p = 0.043 and 0.039, respectively). There was no significant difference between the retinol intake (536.4±170.7 μg RAE) (retinol activity equivalent) of the BPH group and (545.6±870.5 μg RAE) of the controls (p= 0.993).

In Table 3, the serum antioxidant status of the respondents is presented. The mean serum lycopene, beta-carotene and retinol of the BPH were significantly lower than the mean serum lycopene, beta-carotene and retinol of the controls (p<0.05).

There were no significant associations between the respondents’ dietary intakes of energy, protein, fat, calcium, magnesium, iron, sodium, zinc, lycopene, beta-carotene and retinol (p>0.05) and BPH as shown in Table 4. Similarly, no significant associations were observed between the respondents’ serum beta-carotene and retinol (p>0.05) and BPH. However, a significant positive correlation (r = 0.318, p = 0.033) was observed for potassium intake and BPH, while an inverse correlation was observed between the serum lycopene of respondents and BPH (r = -0.552, p = 0.000).

DISCUSSION

Previous studies have indicated that increased adiposity is positively associated with obesity-related metabolic diseases, such as type 2 diabetes, hypertension and dyslipidemia and prostatic hyperplasia21,22. However, this study did not indicate any association between BMI and BPH.

Table 2:Mean daily nutrient intakes of the respondents
*Significant difference detected, aThere are no established DRIs for lycopene and beta-carotene, values are Mean±SD, BPH = Benign prostatic hyperplasia, DRI = Daily recommended intake, SD = Standard deviation

Table 3:Mean serum lycopene, beta-carotene and retinol status of the respondents
*Significant difference detected, values are Mean±SD, BPH = Benign prostatic hyperplasia

Table 4:Correlations between nutrient intakes and BPH
*Significant correlation, BPH = Benign prostatic hyperplasia

The proportion of overweight respondents in this study was higher than the proportions indicated by Oldewage-Theron et al.23 and Lee et al.24. In contrast however, the prevalence of obesity in the current study was much lower than those indicated in these two studies.

The carbohydrate, energy, protein, fat, calcium, retinol, potassium and sodium intakes observed in this study were much lower, while the iron and beta-carotene intakes were higher than those observed among BPH patients in a much older study in Japan25. However, the mean energy intake in this study population was similar to that observed in a healthy population of elderly men in South Africa in a more recent study23. On the contrary, the mean iron and zinc intakes observed in this study were lower than those observed in the study in South Africa24. In the current study, dietary energy intake was not associated with BPH. This is consistent with the findings of Schenk et al.26 and Meigs et al.27, but contrary to the findings of Suzuki et al.28 and Parsons29, who observed direct associations between BPH and energy intakes. Protein intakes were not significantly associated with BPH in this study, contrary to findings by Suzuki et al.28 and Parsons29.

In this study, beta-carotene intakes were observed to be higher than the mean beta-carotene intake observed among BPH patients in Italy30. Similarly, the mean intakes of beta-carotene in this study were also found to be higher than the suggestion of an intake of 3-6 mg/day of β-carotene from food sources to maintain plasma β-carotene concentrations in the range associated with a lower risk of various chronic disease outcomes19. The beta-carotene intakes of the controls in the current study were significantly higher than the BPH group while mean serum beta-carotene levels also differed significantly between the groups. However, a non-significant association was observed between serum beta-carotene concentrations and BPH, in agreement with the findings that a null association exists between serum beta-carotene levels and the risk of prostate enlargement31,32.

The retinol intakes of the respondents in this study were much lower than the DRI for vitamin A. This may be due to low consumption of foods rich in vitamin A. Furthermore, the non-significant association between BPH and retinol intake is comparable to the indication in recent studies that dietary retinol is not associated with BPH30,33,34.

Highly proliferative prostate epithelium as found in BPH is a risk factor for prostate cancer35. Lycopene is a promising component for the prevention of prostate pathologies36. Although there is an abundance of literature on serum lycopene status of prostate cancer patients in various populations, there is little documentation on the serum lycopene status of BPH patients in many populations. The mean serum lycopene concentrations of the respondents in both groups in this study were much lower than those indicated in a study in the United Kingdom37. Furthermore, the mean lycopene intake and mean serum lycopene of the control group were much higher than those of the BPH group. Similarly, we observed a significant negative association between serum lycopene and BPH. These findings are consistent with the indication that evidence for inverse associations of serum lycopene with prostate enlargement exists5.

Further studies need to be carried out to elucidate the relationship between potassium intakes and BPH as there is sparse literature on this topic.

CONCLUSION AND RECOMMENDATIONS

It was concluded that:

Elderly men with BPH had low nutrient intakes. The mean calcium and potassium intakes of men with BPH were significantly higher than that of men without BPH, while the mean lycopene and beta-carotene intakes of men without BPH were significantly higher than those with BPH
The serum lycopene, beta-carotene and retinol status of men with BPH was significantly lower than that of men without BPH
Potassium intake was positively associated, while serum lycopene was negatively associated with BPH

Further epidemiologic studies and clinical trials are necessary to explore the relationship between these antioxidants and prostate enlargement, their role in the reduction of the risk of prostate enlargement and to elucidate the mechanisms by which they modulate the risk of BPH. Stakeholders in nutrition and public health should embark upon extensive nutrition education in Nigeria in order to enlighten the public on the importance of healthy food choices to eliminate antioxidant nutrient deficiencies which can compromise the health of individuals and the well-being of communities. Preventive strategies should be adopted to reduce the risk of prostate enlargement, such as dietary diversification, the consumption of fruits and vegetables, (especially those that are rich in lycopene such as tomatoes) particularly for men who are at a high risk of BPH.

REFERENCES

  • McVary, K.T., 2006. BPH: Epidemiology and comorbidities. Am. J. Managed Care, 12: S122-S128.
    Direct Link    


  • Emberton, M., E.B. Cornel, P.F. Bassi, R.O. Fourcade, J.M.F. Gomez and R. Castro, 2008. Benign prostatic hyperplasia as a progressive disease: A guide to the risk factors and options for medical management. Int. J. Clin. Pract., 62: 1076-1086.
    CrossRef    Direct Link    


  • Ejike, C.E.C.C. and L.U.S. Ezeanyika, 2008. Metabolic syndrome in sub-Saharan Africa: Smaller twin of a region's prostatic diseases? Int. Urol. Nephrol., 40: 909-920.
    CrossRef    Direct Link    


  • Ezeanyika, L.U.S., C.E.C.C. Ejike, O. Obidoa and S.O. Elom, 2006. Prostate disorders in an apparently normal Nigerian population 1: Prevalence. Biokemistri, 18: 127-132.
    Direct Link    


  • Kristal, A.R., K.B. Arnold, J.M. Schenk, M.L. Neuhouser, P. Goodman, D.F. Penson and I.M. Thompson, 2008. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial. Am. J. Epidemiol., 167: 925-934.
    Direct Link    


  • Tubaro, A., 2006. Micronutrients and BPH. Eur. Urol., 50: 413-415.
    CrossRef    Direct Link    


  • Donovan, J.L., H.E. Kay, T.J. Peters, P. Abrams and J. Coas et al., 1997. Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: Evidence from the ICS-'BPH' study. BJU Int., 80: 712-721.
    CrossRef    Direct Link    


  • Wang, S., Q. Mao, Y. Lin, J. Wu, X. Wang, X. Zheng and L. Xie, 2012. Body mass index and risk of BPH: A meta-analysis. Prostate Cancer Prostatic Dis., 15: 265-272.
    CrossRef    Direct Link    


  • Kramer, G., G.E. Steiner, A. Handisurya, U. Stix and A. Haitel et al., 2002. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types and effect of differentially expressed cytokines on stromal cell proliferatio. Prostate, 52: 43-58.
    CrossRef    Direct Link    


  • Rohrmann, S., E. Giovannucci, W.C. Willett and E.A. Platz, 2007. Fruit and vegetable consumption, intake of micronutrients and benign prostatic hyperplasia in US men. Am. J. Clin. Nutr., 85: 523-529.
    Direct Link    


  • Means, A.L. and L.J. Gudas, 1995. The roles of retinoids in vertebrate development. Annu. Rev. Biochem., 64: 201-233.
    Direct Link    


  • Cook, N.R., M.J. Stampfer, J. Ma, J.E. Manson, F.M. Sacks, J.E. Buring and C.H. Hennekens, 1999. β‐carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer, 86: 1783-1792.
    CrossRef    Direct Link    


  • Goyal, A., G.H. Delves, M. Chopra, B.A. Lwaleed and A.J. Cooper, 2006. Prostate cells exposed to lycopene in vitro liberate lycopene‐enriched exosomes. BJU Int., 98: 907-911.
    CrossRef    Direct Link    


  • Obermuller-Jevic, U.C., E. Olano-Martin, A.M. Corbacho, J.P. Eiserich and A. van der Vliet et al., 2003. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J. Nutr., 133: 3356-3360.
    PubMed    


  • Schwarz, S., U.C. Obermuller-Jevic, E. Hellmis, W. Koch, G. Jacobi and H.K. Biesalski, 2008. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J. Nutr., 138: 49-53.
    Direct Link    


  • Wertz, K., U. Siler and R. Goralczyk, 2004. Lycopene: Modes of action to promote prostate health. Arch. Biochem. Biophys., 430: 127-134.
    CrossRef    Direct Link    


  • Tzeng, M.S., F.L. Yang, G.S. Wang-Hsu and B.H. Chen, 2004. Determination of major carotenoids in human serum by liquid chromatography. J. Food Drug Anal., 12: 79-83.


  • Sosanya, M.E., G.T. Fadupin, T. Atinmo and O.B. Shittu, 2014. Anti-oxidant status of male adults with and without prostate cancer in Ibadan, Nigeria. Food Nutr. Sci., 5: 516-524.


  • Food and Nutrition Board and Institute of Medicine, 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. The National Academies Press, USA., pp: 325-382


  • USDA., 2010. Nutrient database for standard reference 2010. US. Department of Agriculture (USDA), Release 23, Agricultural Research Service.


  • Patel, N.D. and J.K. Parsons, 2014. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Ind. J. Urol., 30: 170-176.
    CrossRef    Direct Link    


  • Hammarsten, J. and B. Hogstedt, 2001. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur. Urol., 39: 151-158.
    CrossRef    Direct Link    


  • Oldewage-Theron, W.H., F. Samuel, C. Grobler and A.A. Egal, 2008. Anaemia prevalence and dietary intake of elderly persons living in a peri-urban settlement in South Africa. Tydskrif vir Gesinsekologie en Verbruikerswetenskappe, Vol. 36.
    CrossRef    


  • Lee, S., H.G. Min, S.H. Choi, Y.J. Kim and S.W. Oh et al., 2006. Central obesity as a risk factor for prostatic hyperplasia. Obesity, 14: 172-179.
    CrossRef    Direct Link    


  • Ohno, Y., O. Yoshida, K. Oishi, K. Okada, H. Yamabe and F.H. Schroeder, 1988. Dietary β-carotene and cancer of the prostate: A case-control study in Kyoto, Japan. Cancer Res., 48: 1331-1336.
    Direct Link    


  • Schenk, J.M., G.S. Calip, C.M. Tangen, P. Goodman, J.K. Parsons, I.M. Thompson and A.R. Kristal, 2012. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial. Am. J. Epidemiol., 176: 156-163.
    CrossRef    Direct Link    


  • Meigs, J.B., B. Mohr, M.J. Barry, M.M. Collins and J.B. McKinlay, 2001. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J. Clin. Epidemiol., 54: 935-944.
    CrossRef    Direct Link    


  • Suzuki, S., E.A. Platz, I. Kawachi, W.C. Willett and E. Giovannucci, 2002. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am. J. Clin. Nutr., 75: 689-697.
    Direct Link    


  • Parsons, J.K., 2007. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: New approaches to old problems. J. Urol., 178: 395-401.
    CrossRef    Direct Link    


  • Tavani, A., E. Longoni, C. Bosetti, L. dal Maso and J. Polesel et al., 2006. Intake of selected micronutrients and the risk of surgically treated benign prostatic hyperplasia: A case-control study from Italy. Eur. Urol., 50: 549-554.
    CrossRef    Direct Link    


  • Key, T.J., P.N. Appleby, N.E. Allen, R.C. Travis and A.W. Roddam et al., 2007. Plasma carotenoids, retinol and tocopherols and the risk of prostate cancer in the European prospective investigation into cancer and nutrition study. Am. J. Clin. Nutr., 86: 672-681.
    Direct Link    


  • Watters, J.L., M.H. Gail, S.J. Weinstein, J. Virtamo and D. Albanes, 2009. Associations between α-tocopherol, β-carotene and retinol and prostate cancer survival. Cancer Res., 69: 3833-3841.
    CrossRef    Direct Link    


  • Beilby, J., J.L. Ambrosini, E. Rossi, N.H. de Klerk and A.W. Musk, 2010. Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk. Eur. J. Clin. Nutr., 64: 1235-1238.
    CrossRef    Direct Link    


  • Bosetti, C., R. Talamini, M. Montella, E. Negri, E. Conti, S. Franceschi and C. La Vecchia, 2004. Retinol, carotenoids and the risk of prostate cancer: A case‐control study from Italy. Int. J. Cancer, 112: 689-692.
    CrossRef    Direct Link    


  • De Marzo, A.M., M.J. Putzi and W.G. Nelson, 2001. New concepts in the pathology of prostatic epithelial carcinogenesis. Urology, 57: 103-114.
    CrossRef    Direct Link    


  • Herzog, A., U. Siler, V. Spitzer, N. Seifert and A. Denelavas et al., 2005. Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB J., 19: 272-274.
    CrossRef    PubMed    Direct Link    


  • Almushatat, A.S.K., D. Talwar, P.A. McArdle, C. Williamson and N. Sattar et al., 2006. Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. Int. J. Cancer, 118: 1051-1053.
    CrossRef    PubMed    Direct Link    

  • © Science Alert. All Rights Reserved